A detailed history of Venturi Wealth Management, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Venturi Wealth Management, LLC holds 1,500 shares of BPMC stock, worth $141,525. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,500
Holding current value
$141,525
% of portfolio
0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025

BUY
$82.48 - $101.39 $123,720 - $152,085
1,500 New
1,500 $130,000
Q3 2019

Oct 29, 2019

BUY
$72.9 - $101.41 $801 - $1,115
11 New
11 $1,000

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.63B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Venturi Wealth Management, LLC Portfolio

Follow Venturi Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Venturi Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Venturi Wealth Management, LLC with notifications on news.